Willingness to pay for three hypothetical malaria vaccines in Nigeria

Clinical Therapeutics

Volumn 32, Issue 8, 2010, Pages 1533-1544

  Udezi, Waka Anthony ^a   Usifoh, Cyril Odianose ^a   Ihimekpen, Omoyeme Oluwatosin ^a  

^a UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Access; Affordability; Malaria; Nigeria; Vaccine; Willingness to pay

Indexed keywords

MALARIA VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEALTH CARE COST; HEALTH ECONOMICS; HEALTH INSURANCE; HEALTH SURVEY; HUMAN; IMMUNITY; INCOME; MALARIA; MALE; NIGERIA; PREGNANT WOMAN; PRESCRIPTION; QUESTIONNAIRE; SOCIAL STATUS;

ADOLESCENT; ADULT; DATA INTERPRETATION, STATISTICAL; FEMALE; FINANCING, PERSONAL; HUMANS; LINEAR MODELS; MALARIA; MALARIA VACCINES; MALE; MIDDLE AGED; NIGERIA; PATIENT ACCEPTANCE OF HEALTH CARE; PREGNANCY; QUESTIONNAIRES; SOCIOECONOMIC FACTORS; YOUNG ADULT;

EID: 77955907907     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2010.07.018     Document Type: Article

References (26)

1. Uguru NP, Onwujekwe OE, Uzochukwu BS, et al. Inequities in incidence, morbidity and expenditures on prevention and treatment of malaria in southeast Nigeria. BMC Int Health Hum Rights 2009, 9:21.
2. Hay SI, Guerra CA, Tatem AJ, et al. Urbanization, malaria transmission and disease burden in Africa. Nat Rev Microbiol 2005, 3:81-90.
3. Russell S The economic burden of illness for households in developing countries: A review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/ acquired immunodeficiency syndrome. Am J Trop Med Hyg. 2004, 71(Suppl 2):47-155.
4. Laxminarayan R Does reducing malaria improve household living standard?. Trop Med Int Health 2004, 9:267-272.
5. Greenwood B, Mutabingwa T Malaria in 2002. Nature 2002, 415:670-672.
6. Gallup JL, Sachs JD The economic burden of malaria. Am J Trop Med Hyg. 2001, 64(Suppl 1-2):85-96.
7. Udezi WA, Usifoh CO, Eze UI Affordability of antimalarial drugs in Benin City, Nigeria. Value Health 2007, 10:A447. Abstract.
8. Sauerborn R, Gbangou A, Dong H, et al. Willingness to pay for hypothetical malaria vaccines in rural Burkina Faso. Scand J Public Health 2005, 33:146-150.
9. Targett GA, Greenwood BM Malaria vaccines and their potential role in the elimination of malaria. Malar J. 2008, 7(Suppl 1):S10.
10. Kinyanjui SM, Bejon P, et al. What you see is not what you get: Implications of the brevity of antibody responses to malaria antigens and transmission heterogeneity in longitudinal studies of malaria immunity. Malar J. 2009, 8:242.
11. Vanderberg JP Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond. Vaccine 2009, 27:2-9.
12. Ellis RD, Martin LB, Shaffer D, et al. Phase 1 trial of the Plasmodium falciparum blood stage vaccine MSP1(42)-C1/ Alhydrogel with and without CPG 7909 in malaria naive adults. PLoS One 2010, 5:e8787.
13. Social Statistics in Nigeria 2009 National Bureau of Statistics, Accessed July 19, 2010. http://www.nigerianstat.gov.ng/ext/latest_release/ssd09.pdf.
14. Wagbatsoma VA, Omoike BI Prevalence and prevention of malaria in pregnancy in Edo State, Nigeria. Afr J Reprod Health 2008, 12:49-58.
15. Olsen JA, Donaldson C Helicopters, hearts and hips: Using willingness to pay to set priorities for public sector health care programmes. Soc Sci Med. 1998, 46:1-12.
16. Thomas R, Donalson C, Torgerson D Who answers 'willingness to pay' questions?. J Health Serv Res Policy 2000, 5:7-11.
17. Donaldson C, Shackley P, Abdalla M, Miedzybrodzka Z Willingness to pay for antenatal carrier screening for cystic fibrosis. Health Econ. 1995, 4:439-452.
18. Donaldson C, Farrer S, Mapp T, et al. Assessing community values in health care: Is the 'willingness to pay' method feasible?. Health Care Anal 1997, 5:7-29.
19. Yasunaga H, Ide H, Imamura T, Ohe K Willingness to pay for health care services in common cold, retinal detachment, and myocardiac infarction: An internet survey in Japan. BMC Health Serv Res. 2006, 6:12.
20. Chuck A, Adamowicz W, Jacobs P, et al. The willingness to pay for reducing pain and pain-related disability. Value Health 2009, 12:498-506.
21. Kartman B, Andersson F, Johannes-son M Willingness to pay for reductions in angina pectoris attacks. Med Decis Making 1996, 16:248-253.
22. Chestnut LG, Keller LR, Lambert WE, Rowe RD Measuring heart patients' willingness to pay for changes in angina symptoms. Med Decis Making 1996, 16:65-77.
23. Human Development Report 2009 2009, United Nations Development Programme, Palgrave Mac-millan, New York, NY.
24. Lenert LA Use of willingness to pay study values for pharmacotherapies for migraine headache. Med Care 2003, 41:299-308.
25. Hamelsky SW, Lipton RB, Stewart WF An assessment of the burden of migraine using the willingness to pay model. Cephalalgia 2005, 25:87-100.
26. Saulo EC, Forsberg BC, Premji Z, et al. Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania. Malar J. 2008, 7:227.